Alfresa Holdings Corporation (TYO:2784)

Market Cap	457.20B +23.5%
Revenue (ttm)	3.06T +4.1%
Net Income	33.64B -2.2%
EPS	184.82 +0.3%
Shares Out	181.72M
PE Ratio	13.61
Forward PE	14.53
Dividend	68.00 (2.62%)
Ex-Dividend Date	Mar 30, 2026

Volume	513,200
Average Volume	348,485
Open	2,616.00
Previous Close	2,516.00
Day's Range	2,548.00 - 2,632.50
52-Week Range	1,897.00 - 2,685.50
Beta	-0.27
RSI	50.76
Earnings Date	Feb 10, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In fiscal year 2025, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.